Structure and Ligand Based Drug Design Strategies in the Development of Novel 5- LOX Inhibitors

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|19|22|3763-3778

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.19, Iss.22, 2012-08, pp. : 3763-3778

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Discovery of HIV-1 Integrase Inhibitors through a Novel Combination of Ligand and Structure-based Drug Design

By  

Medicinal Chemistry, Vol. 1, Iss. 3, 2005-05 ,pp. : 263-275

Bentham Science Publishers

Access to resources Recommend Favorite

Structure and Ligand-Based Drug Design to Propose Novel -Glucosidase Inhibitors

By  

Current Bioactive Compounds, Vol. 5, Iss. 2, 2009-06 ,pp. : 99-109

Bentham Science Publishers

Access to resources Recommend Favorite

Ligand-Based Drug Design of Novel MARK-3 Inhibitors in Cancer

By  

Current Bioactive Compounds, Vol. 10, Iss. 2, 2014-07 ,pp. : 112-123

Bentham Science Publishers

Access to resources Recommend Favorite

Structure and Ligand Based Rational Drug Design for Bace-1 Inhibitors

By  

Current Bioactive Compounds, Vol. 9, Iss. 1, 2013-03 ,pp. : 14-20

Bentham Science Publishers

Access to resources Recommend Favorite

Structure-Based Drug Design of Novel MARK-3 Inhibitors in Cancer

By  

Current Bioactive Compounds, Vol. 10, Iss. 2, 2014-07 ,pp. : 131-138

Bentham Science Publishers

Access to resources Recommend Favorite